Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NBIX

Neurocrine

$85.42

0.58 (0.68%)

, ABBV

AbbVie

$117.56

-0.35 (-0.30%)

07:07
02/23/18
02/23
07:07
02/23/18
07:07
Recommendations
Neurocrine, AbbVie analyst commentary at Oppenheimer »

Neurocrine 'going…

NBIX

Neurocrine

$85.42

0.58 (0.68%)

ABBV

AbbVie

$117.56

-0.35 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

Thursday
NBIX

Neurocrine

$84.84

0.26 (0.31%)

, ABBV

AbbVie

$117.91

-0.07 (-0.06%)

08:35
02/22/18
02/22
08:35
02/22/18
08:35
Recommendations
Neurocrine, AbbVie analyst commentary at Needham »

Neurocrine price target…

NBIX

Neurocrine

$84.84

0.26 (0.31%)

ABBV

AbbVie

$117.91

-0.07 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

Wednesday
ABBV

AbbVie

$117.98

-0.62 (-0.52%)

, NBIX

Neurocrine

$84.58

-0.67 (-0.79%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Hot Stocks
AbbVie: Phase 3 ELARIS UF-I study of elagolix met primary endpoint »

AbbVie (ABBV) in…

ABBV

AbbVie

$117.98

-0.62 (-0.52%)

NBIX

Neurocrine

$84.58

-0.67 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

Tuesday
NBIX

Neurocrine

$85.25

-0.32 (-0.37%)

07:06
02/20/18
02/20
07:06
02/20/18
07:06
Recommendations
Neurocrine analyst commentary at Leerink »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

Over a week ago
TRIP

TripAdvisor

$40.72

0.84 (2.11%)

, SEDG

SolarEdge

$36.90

0.9 (2.50%)

17:39
02/14/18
02/14
17:39
02/14/18
17:39
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

TRIP

TripAdvisor

$40.72

0.84 (2.11%)

SEDG

SolarEdge

$36.90

0.9 (2.50%)

CTL

CenturyLink

$17.58

0.37 (2.15%)

CUTR

Cutera

$46.65

0.7 (1.52%)

CSCO

Cisco

$42.09

0.86 (2.09%)

LPI

Laredo Petroleum

$7.93

0.36 (4.76%)

A

Agilent

$69.70

1.36 (1.99%)

CF

CF Industries

$39.66

0.66 (1.69%)

MRO

Marathon Oil

$16.95

0.88 (5.48%)

COOL

PolarityTE

$20.30

1.1 (5.73%)

TEVA

Teva

$19.33

0.81 (4.37%)

NBIX

Neurocrine

$85.38

1.69 (2.02%)

BRK.A

Berkshire Hathaway

$301,005.00

3505 (1.18%)

BRK.B

Berkshire Hathaway

$200.54

2.55 (1.29%)

NTAP

NetApp

$60.64

1.9 (3.23%)

QTWO

Q2 Holdings

$43.75

0.55 (1.27%)

SPWR

SunPower

$7.48

0.1 (1.36%)

MAR

Marriott

$145.24

4.63 (3.29%)

EQIX

Equinix

$435.83

-0.42 (-0.10%)

XEC

Cimarex Energy

$102.19

2.49 (2.50%)

CDMO

Avid Bioservices

$3.25

0.03 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 16

    Feb

  • 22

    Feb

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 26

    Feb

  • 26

    Feb

  • 05

    Mar

  • 06

    Mar

  • 08

    Mar

  • 13

    Mar

  • 14

    Mar

  • 15

    Mar

  • 25

    Mar

  • 27

    Mar

  • 29

    Mar

  • 29

    Mar

  • 30

    May

  • 15

    Feb

NBIX

Neurocrine

$85.38

1.69 (2.02%)

16:24
02/14/18
02/14
16:24
02/14/18
16:24
Hot Stocks
Neurocrine to file NDA for opicapone for Parkinson's Disease »

Neurocrine Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 08

    Mar

NBIX

Neurocrine

$83.69

1.52 (1.85%)

07:53
02/14/18
02/14
07:53
02/14/18
07:53
Recommendations
Neurocrine analyst commentary at Oppenheimer »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 08

    Mar

NBIX

Neurocrine

$83.69

1.52 (1.85%)

05:17
02/14/18
02/14
05:17
02/14/18
05:17
Recommendations
Neurocrine analyst commentary at Deutsche Bank »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 08

    Mar

NBIX

Neurocrine

$83.69

1.52 (1.85%)

04:52
02/14/18
02/14
04:52
02/14/18
04:52
Recommendations
Neurocrine analyst commentary at Barclays »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 08

    Mar

FOSL

Fossil

$9.04

0.65 (7.75%)

, CCS

Century Communities

$29.30

0.35 (1.21%)

17:34
02/13/18
02/13
17:34
02/13/18
17:34
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Fossil…

FOSL

Fossil

$9.04

0.65 (7.75%)

CCS

Century Communities

$29.30

0.35 (1.21%)

TWLO

Twilio

$26.44

0.65 (2.52%)

CARB

Carbonite

$21.70

0.55 (2.60%)

BIDU

Baidu

$225.60

3.96 (1.79%)

FANG

Diamondback Energy

$115.03

-0.98 (-0.84%)

WU

Western Union

$19.75

-0.02 (-0.10%)

CMG

Chipotle

$251.33

-3.12 (-1.23%)

IPCC

Infinity Property

$96.05

-1 (-1.03%)

KMPR

Kemper

$57.55

-0.2 (-0.35%)

ECOM

ChannelAdvisor

$9.35

-0.05 (-0.53%)

NBIX

Neurocrine

$83.69

1.52 (1.85%)

OXY

Occidental Petroleum

$69.72

-0.15 (-0.21%)

OHI

Omega Healthcare

$26.96

0.58 (2.20%)

TTPH

Tetraphase

$5.43

-0.03 (-0.55%)

PIRS

Pieris Pharmaceuticals

$9.45

0.57 (6.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 13

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 20

    Feb

  • 21

    Feb

  • 26

    Feb

  • 27

    Feb

  • 08

    Mar

  • 04

    Apr

  • 30

    May

  • 14

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.